Avadel Pharmaceuticals plc
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AVDL research report →
Companywww.avadel.com
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017.
- CEO
- Gregory J. Divis Jr.
- IPO
- 1996
- Employees
- 188
- HQ
- Dublin, IE
Price Chart
Valuation
- Market Cap
- $2.12B
- P/E
- -7558.74
- P/S
- 8.55
- P/B
- 21.39
- EV/EBITDA
- 205.48
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 94.47%
- Op Margin
- 1.82%
- Net Margin
- -0.11%
- ROE
- -0.33%
- ROIC
- 0.28%
Growth & Income
- Revenue
- $169.12M · 504.79%
- Net Income
- $-48,832,000 · 69.53%
- EPS
- $-0.51 · 74.50%
- Op Income
- $-42,399,000
- FCF YoY
- 63.50%
Performance & Tape
- 52W High
- $23.57
- 52W Low
- $6.38
- 50D MA
- $21.50
- 200D MA
- $15.49
- Beta
- 1.31
- Avg Volume
- 2.42M
Get TickerSpark's AI analysis on AVDL
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 13, 26 | Weiss Asset Management LP | sell | 11,112,052 |
| Feb 11, 26 | Weiss Asset Management LP | other | 0 |
| Feb 12, 26 | Rodriguez Susan | sell | 300,000 |
| Feb 12, 26 | Thornton Peter J. | sell | 42,000 |
| Feb 12, 26 | Thornton Peter J. | sell | 42,000 |
| Feb 12, 26 | Thornton Peter J. | sell | 11,000 |
| Feb 12, 26 | Thornton Peter J. | sell | 42,000 |
| Feb 12, 26 | Thornton Peter J. | sell | 115,060 |
| Feb 12, 26 | Thornton Peter J. | sell | 60,000 |
| Feb 12, 26 | Thornton Peter J. | sell | 33,000 |
Our AVDL Coverage
We haven't published any research on AVDL yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AVDL Report →